Effect of Chlorhexidine gel in diabetic and gum disease patients
- Conditions
- chronic periodontitis.Chronic pericoronitis Periodontitis: NOS complex simplex
- Registration Number
- IRCT201411023690N5
- Lead Sponsor
- Vice Chancellor for research of Tabriz University of Medical Sciences, School of Dentistry, Tabriz,
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 33
presence of type 2 diabetes ; HbA1c = 6.0% ; Clinical Diagnosis of moderate generalized chronic periodontists defined by loss of clinical attachment more than 3mm and bone loss more than 30% ; Presence of more than 10 teeth per dental arch, excluding third molars ; No previous periodontal treatment taken ; signing informed consent, and commitment to post treatment follow-up visits ; no modification in medication for two months, before or during the study
exclusion criteria: Presence of systemic disease that could influence the course of periodontal disease ; Intake of anti-inflammatory antibiotics for four weeks before the study ; current smokers or ex-smokers of <5 years ; Pregnancy or intention to be pregnant during the six months of study ; Intake of periodontal treatment in 3 months ago ;
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method HbA1c. Timepoint: Before the experiment, three months after the intervention, six months after the intervention. Method of measurement: Examination.
- Secondary Outcome Measures
Name Time Method Fast Blood Sugur (FBS). Timepoint: Befoer the experiment (Baseline) , 3 months after the intervention, 6 month after the intervention. Method of measurement: Examination.;Clinical attachment level (CAL). Timepoint: Befoer the experiment (Baseline) , 3 months after the intervention, 6 month after the intervention. Method of measurement: with periodontal prob from CEJ to pocket depth.;Probing depth (PD). Timepoint: Befoer the experiment (Baseline) , 3 months after the intervention, 6 month after the intervention. Method of measurement: with periodontal prob.;Plaque Index. Timepoint: Befoer the experiment (Baseline) , 3 months after the intervention, 6 month after the intervention. Method of measurement: Disclosing tablets.;Bleeding Index (BI). Timepoint: Befoer the experiment (Baseline) , 3 months after the intervention, 6 month after the intervention. Method of measurement: observe.